In summary, BRCA2 deficiency potentiated the sensitivity of CRC cells towards all tested PARPi (Olaparib » veliparib > X17613 ≈ X17618), while ATR deficiency only increased sensitivity towards olaparib. The gene discussed is BRCA2; the disease is colorectal carcinoma.